Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 831, pseudogene (RNU6-831P) is a pseudogene derived from the U6 family of small nuclear RNAs (snRNAs)[2][5]. U6 snRNA is a highly conserved non-coding RNA involved in the splicing process as a core part of the spliceosome complex, essential for excising introns from pre-mRNA in eukaryotic nuclei[7][3]. However, RNU6-831P is not a functional protein-coding gene or a biologically active non-coding RNA; rather, it is a non-functional (pseudogenized) genomic sequence derived from retrotransposition or duplication events involving U6 snRNA genes[5]. Such snRNA pseudogenes do not encode functional products, do not participate in cellular pathways, have no known disease-association or role as a therapeutic target, and lack pharmacologically relevant interactions[5][4]. Their main biological significance is as markers of past retrotransposition events and genome evolution, particularly showing the activity of LINE-1 retrotransposons on snRNA sequences[5]. There is no evidence that pseudogenes of U6 snRNA, including RNU6-831P, have direct physiological or pathological function, serve as therapeutic biomarkers, or are targeted by drugs. Key note: - This target is a pseudogene (relic RNA gene, non-functional) and not a receptor, enzyme, or therapeutic target. - No biological, disease, or pharmacological relevance is established for this entity, and it is not relevant for drug discovery or clinical selection[5][2]. - The entry represents a genomic annotation artifact or sequence of evolutionary interest, but not a functional molecular target for therapy or biomarker development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 831, pseudogene (RNU6-831P).